Company: IXHL
Filing Date: 2025-04-17
Form Type: PRER14A
Source: 0001213900-25-033013
Chunk: 29

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-17
Form: PRER14A
Chunk 29
---
, reclassification or similar transaction.

“Release Date” means the later of
(x) the earlier of (i) the effective date of the registration statement registering all of the securities sold in the Private Placement
or (ii) the date that the securities sold in the Private Placement can be sold, assigned or transferred without restriction or limitation
pursuant to Rule 144 or Rule 144A promulgated under the Securities Act of 1933 and (y) the date that the Company obtains the Warrant Stockholder
Approval.

Warrant Stockholder Approval.Under Nasdaq
listing rules, the Series A Warrants may not be exercised unless and until we obtain the approval of our stockholders. Pursuant to the
terms of the Series A Warrants, we agreed that if we fail to obtain the full Warrant Stockholder Approval we will seek the Warrant Stockholder
Approval every 60 days following such a failure (and following any such future failure) until the Warrant Stockholder Approval is obtained.

Transferability.Subject to applicable
laws, the Warrants may be offered for sale, sold, transferred or assigned without our consent.

Exchange Listing.We do not intend to apply
for the listing of the Warrants on any stock exchange. Without an active trading market, the liquidity of the Warrants will be limited.

Rights as a Stockholder. Except as described
above or by virtue of a holder’s ownership of shares of our common stock, the holder of a Warrant does not have the rights or privileges
of a holder of our shares of common stock, including any voting rights, until the holder exercises the Warrant.

Fundamental Transaction. In the event of
a fundamental transaction, as described in the Warrants, and generally including, with certain exceptions, any reorganization, recapitalization
or reclassification of our shares of common stock, the sale, transfer or other disposition of all or substantially all of our properties
or assets, our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding shares of common
and preferred stock, or any person or group becoming the beneficial owner of more than 50% of the voting power represented by our outstanding
shares of common stock and preferred stock, the holders of the Warrants will be entitled to receive upon exercise thereof the kind and
amount of securities, cash or other property that the holders would have received had they exercised the Warrants immediately prior to
such fundamental transaction. In addition, in certain circumstances,